Management of malignant hypertension complicated by renal insufficiency. A follow-up study. 1974

J W Woods, and W B Blythe, and W D Huffines

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D006974 Hypertension, Malignant A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction. Malignant Hypertension
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

J W Woods, and W B Blythe, and W D Huffines
October 1967, Lancet (London, England),
J W Woods, and W B Blythe, and W D Huffines
January 1971, Marseille medical,
J W Woods, and W B Blythe, and W D Huffines
July 1968, Canadian Medical Association journal,
J W Woods, and W B Blythe, and W D Huffines
August 1977, Nihon Jinzo Gakkai shi,
J W Woods, and W B Blythe, and W D Huffines
January 2009, BMJ case reports,
J W Woods, and W B Blythe, and W D Huffines
January 1952, Bulletin de la Federation des societes de gynecologie et dobstetrique de langue francaise,
J W Woods, and W B Blythe, and W D Huffines
January 2002, Journal of nephrology,
J W Woods, and W B Blythe, and W D Huffines
January 1995, Contemporary internal medicine,
J W Woods, and W B Blythe, and W D Huffines
January 1979, Scandinavian journal of urology and nephrology,
J W Woods, and W B Blythe, and W D Huffines
September 1967, Annals of surgery,
Copied contents to your clipboard!